Sponsorship & exhibition
Download PDF Brochure
Browse interactive brochure
Dear Sir, Madam,
We are writing this letter to request your support of the 17th International Congress on Pediatric Pulmonology – CIPP XVII – to be held in Toledo, Spain, June 21-24, 2018.
We invite you to support this meeting by way of a display booth, support a scientifi c session, organization of satellite symposia or support of one of the Young Investigator prizes or the poster award, or the proceedings (published as a supplement of Pediatric Pulmonology / Wiley)…
Alternative option would be to support the participation of pediatric pulmonary physicians at all levels to attend this meeting, or having representatives from you own organization register and attend the meeting.
Please see the options outlined in the accompanying material.
In the 20 years of its activity, CIPP has emerged as the single most signifi cant standalone international pediatric pulmonology conference, and our recent meetings were able to attract over 800 delegates from around the world (70 countries were presented at CIPP XVI Lisbon). Together with its sister course (International Course on Pediatric Pulmonology – ICPP 14 The Course), it has become the leading platform of exchange of ideas, education, and cross-fertilization of pediatric pulmonologists worldwide.
Despite the attendance record, we remain dependant on industry sponsorship to be ale to sustain our excellence. Starting 2011, CIPP became an annual event and at each of our meetings our sponsors will have direct access to this wide panel of the most prominent specialists and researchers in the fi eld of Pediatric Pulmonology.
Please feel free to contact any of us directly if you have any questions regarding this important international meeting, or contact the CIPP XVII secretariat (details below)
The CIPP Founding Fathers:
Dear Industry Partners,
On behalf of the Executive Committee and the International Advisory Board of the International Congress of Pediatric Pulmonology (CIPP), it is a pleasure to invite you to participate in the forthcoming CIPP XVII Congress due to be held in Toledo, Spain, from June 21-24 2017.
CIPP is the only international meeting devoted exclusively to paediatric pulmonology. Over the period of more than two decades, CIPP has acquired an excellent reputation among practicing paediatricians and clinical academics as the premiere forum for sharing the new information in all areas of paediatric pulmonology, and as a unique place for interactions between the clinical and academic communities. Adding to the series of highly successful congresses in the previous 22 years, the CIPP XV which was held in June 2017 in Lisbon, Portugal, was attended by 600+ doctors treating children with respiratory diseases from over 70 countries.
The CIPP faculty comprises leading specialists and researchers from all parts of the world, bound by the common purpose of improving the management of our young patients. Uniquely, the faculty includes strong participation from the low- and middle-income countries, off ering a rare window of opportunity for the developed and developing world to learn from each other.
In addition to the plenary sessions and topic symposia, CIPP off ers a number of interactive sessions, including research presentations, clinical case discussions, chest imaging quiz, sleep-related disorders, and bronchoscopy and lung function courses. Another unique aspect of the congress is a strong focus on the next generation of leaders, with a forum for Young Investigators to present their exciting work in unopposed sessions, and an Award program to promote attendance and active participation of junior researchers.
The program for CIPP XVI was fi nalised by the co-chairs of the Abstract and Award Committee (Dr. Sejal Seglani, UK, and Dr Giovanni Rossi, Italy), together with the CIPP Executive Committee. The areas which will be covered include the broad range of paediatric respiratory disorders, such as asthma and respiratory allergies, respiratory infections and their complications, neonatal lung diseases and their outcomes, cystic fi brosis, sleep disorders, critical care, rare lung diseases etc. The industry-sponsored symposia and exhibits will off er an opportunity for our industry partners to provide an update and any new information on existing treatments, as well as the novel therapies currently in the various stages of development.
The forthcoming CIPP XVII promises to be the most exciting CIPP congress to date, and will again attract large number of participants from the Americas, Europe, Middle East and Asia.
We are inviting you to be a partner with CIPP in this exciting endeavour which will provide a unique forum for the exchange of information and ideas, and a vehicle for developing long lasting relationships.
Renato T.MD PhD,
President, CIPP XVII